Read your latest personalised notifications
No account yet? Start here
Don't miss out
Ok, got it
Stroke prevention and rhythm control Therapy: Evaluation of an Educational Programme of the European society of cardiology in a cluster-Randomised trial in patients with Atrial Fibrillation. (STEEER-AF)
Atrial Fibrillation (AF) is the most common sustained cardiac arrhythmias, with one in four middle-aged adults in developed countries expected to develop AF. By 2030, 14-17 million AF patients are anticipated in the European Union, with 120,000 – 215,000 newly diagnosed patients per year.
In 2014 the ESC performed a need assessment to understand the educational needs of cardiologists, neurologists & GPs/FPs in 6 countries in the following area:
This study identified that gaps in knowledge and skills of physicians is a major factor in poor adherence to guidelines. The two domains of AF therapy that most determine patient outcomes, namely stroke prevention and appropriate use of rhythm control, were also the two areas most in need of improvement.
This need assessment is now supporting the development of evidence-based educational interventions to be deployed in Germany, France, Italy, Spain, UK and Poland.
A quantitative study using Cluster Randomised trial in patients with Atrial Fibrillation will be used to assess outcome.
The STEEER-AF project study is supported by Boston Scientific, Boehringer Ingelheim, BMS/Pfizer Alliance, Daiichi Sankyo and Bayer in the form of an educational grant.
Our mission: To reduce the burden of cardiovascular disease
© 2018 European Society of Cardiology. All rights reserved